Telemedicine has a lot of regulatory hurdles to get to market, but initiatives like this are extremely exciting, since they can likely be taken to market in a way that explicitly clarifies that it's not a diagnostic, it's simply a low barrier way to actually get that mole you've got looked at. If you don't have health insurance, you could actually get an idea of how critical it is to get in to see a doctor. That said, the obvious concern would be the extreme cost of a false negative (although the evidence suggests that the algorithm is no more likely to provide one than a doctor, the concern over single accidents caused by self-driving cars, even when the overall rates are far lower makes it pretty clear that the bar for success to the public for non-humans is substantially higher than it is for humans)